Viewing Study NCT03771157


Ignite Creation Date: 2025-12-24 @ 6:45 PM
Ignite Modification Date: 2026-02-23 @ 4:10 AM
Study NCT ID: NCT03771157
Status: COMPLETED
Last Update Posted: 2024-03-15
First Post: 2018-12-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors
Sponsor:
Organization: